innovhem sickle cell disease

Innovations to reduce health inequalities

A research company focused on improving the health of sickle cell patients

Sickle cell disease is the most prevalent genetic disease worldwide. Even though it was discovered at the beginning of the 20th century, it is still a:

GLOBAL PUBLIC HEALTH ISSUE

5 million people affected

30 year reduction in life expectancy

Debilitating disease

SIGNIFICANT BURDEN

High social impact

High clinical costs

HIGH UNMET MEDICAL NEED

Lack of treatments

Poor utility of standard-of-care

Lack of diagnostic tools

OUR UNIQUE POSITIONING :

CHANGE THE PARADIGM OF SICKLE CELL MEDICAL CARE

Our solutions

Innovative biomarkers and clinical algorithms

picto innovhem research company focused on improving health of sickle cell patients

TO ASSESS THE EFFICACY OF TREATMENTS

picto innovhem research company focused on improving health of sickle cell patients

TO GUIDE PHYSICIANS TO PERSONALIZE TREATMENTS

Innovations

Biomarkers

 
Our biomarkers, specifically tailored to the pathophysiology of the disease, provide valuable insight to accurately assess treatment efficacy.

blue picto innovhem research company focused on improving health of sickle cell patients

Single cell quantification of fetal hemoglobin

blue picto innovhem research company focused on improving health of sickle cell patients

Intravascular hemolysis biomarkers

Single-cell HbF quantification

Intravascular hemolysis

CLINICAL ALGORITHMS

Unique predictive clinical scores combining a set of biomarkers and machine learning:

predict to avoid innovations clinical algorithms innovhem sickle cell disease

PREDICT TO AVOID

RESEARCH PROGRAMS 

blue picto innovhem research company focused on improving health of sickle cell patients

Validation of the first clinical algorithm to predict painful crises

blue picto innovhem research company focused on improving health of sickle cell patients

Identification of the determinants of organ damage

Our solutions for…

our solution for patients innovhem biotech sickle cell research

PATIENTS

to better understand
your disease

our solution for clinical providers innovhem biotech sickle cell research

CLINICAL PROVIDERS

to better follow-up
and treat your patients

our solution for pharma biotch innovhem biotech sickle cell research

PHARMA / BIOTECH

to support the development
of new therapies

research services biological assays innovhem sickle cell desease

Research services

A platform of unique biological assays to meet the needs of pharma and biotech companies, in terms of validation of clinical claims, with expert innovations.

News

Join our team